Impact of metformin versus repaglinide on non-glucaemic cardiovascular risk markers related to inflammation and endothelial dysfunction in non-obese patients with type 2 diabetes

Authors :: Lund, Søren S
Tarnow, Lise
Stehouwer, Coen DA
Schalwwijk, Casper G
Teerlink, Tom
Gram, Jørgen Brodersen
Winther, Kaj
Frandsen, Merete
Smidt, Ulla M
Pedersen, Oluf
Parving, Hans-Henrik
Vaag, Allan A
Source :: Lund, S S, Tarnow, L, Stehouwer, C DA, Schalwwijk, C G, Teerlink, T, Gram, J B, Winther, K, Frandsen, M, Smidt, U M, Pedersen, O, Parving, H-H & Vaag, A A 2008, ' Impact of metformin versus repaglinide on non-glucaemic cardiovascular risk markers related to inflammation and endothelial dysfunction in non-obese patients with type 2 diabetes ', European Journal of Endocrinology, vol. 158, pp. 631-641 .
Publication Year :: 2008

Language :: English
Database :: OpenAIRE
Journal :: Lund, S S, Tarnow, L, Stehouwer, C DA, Schalwwijk, C G, Teerlink, T, Gram, J B, Winther, K, Frandsen, M, Smidt, U M, Pedersen, O, Parving, H-H & Vaag, A A 2008, ' Impact of metformin versus repaglinide on non-glucaemic cardiovascular risk markers related to inflammation and endothelial dysfunction in non-obese patients with type 2 diabetes ', European Journal of Endocrinology, vol. 158, pp. 631-641 .
Accession number :: edsair.od......3062..7570f13f91bb64a95c8f9651412f5e3c

Tools